https://www.selleckchem.com/pr....oducts/enarodustat.h
SAL proved effective in comparison to multiport access regardless of disease severity providing significantly reduced operative access costs ( 100€case) and postoperative hospital stay (median 5 d 7.5 d, = 0.045) without increasing operative time. It proved especially efficient in those with preoperative albumin 30 g/dL ( = 2. Its comparative advantages were further confirmed in ten pairs case-matched for gender, body mass index and preoperative albumin. SAL outcomes proved durable in the intermediate term (median follow-
Like
Comment
Share
